INS and type 2 diabetes mellitus: T2DM not only desensitizes insulin signaling in the brain (Blazquez et al., 2014), it also enhances inflammation markers such as levels of pro-inflammatory cytokines (Herder et al., 2013; Illien-Junger et al., 2013; Denver et al., 2018).